• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation.

作者信息

Eriksson T, Björkman S, Fyge A, Ekberg H

机构信息

Hospital Pharmacy, Malmö General Hospital, Sweden.

出版信息

J Chromatogr. 1992 Nov 6;582(1-2):211-6. doi: 10.1016/0378-4347(92)80321-g.

DOI:10.1016/0378-4347(92)80321-g
PMID:1491043
Abstract

Thalidomide was determined in plasma and blood by reversed-phase high-performance liquid chromatography with ultraviolet detection. The coefficient of variation of the assay was 1-2% over the 0.25-4.0 micrograms/ml concentration range. Hydrolysis of thalidomide during storage and work-up of the samples was avoided by the addition of an equal volume of citrate buffer, pH 1.5. The assay could be applied to the determination of blood concentrations of thalidomide in rats for at least 28 h after a single oral dose, with multiple blood sampling from the same animal.

摘要

相似文献

1
Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation.
J Chromatogr. 1992 Nov 6;582(1-2):211-6. doi: 10.1016/0378-4347(92)80321-g.
2
Determination of the thalidomide analogues 2-(2,6-dioxopiperidine-3-yl)phthalimidine (EM 12), 2-(2,6-dioxopiperidine-4-yl)phthalimidine (EM 16) and their metabolites in biological samples.生物样品中沙利度胺类似物2-(2,6-二氧代哌啶-3-基)邻苯二甲酰亚胺(EM 12)、2-(2,6-二氧代哌啶-4-基)邻苯二甲酰亚胺(EM 16)及其代谢物的测定。
J Chromatogr. 1989 Mar 24;488(2):417-25. doi: 10.1016/s0378-4347(00)82965-5.
3
Quantitative determination of thalidomide in human serum with high-performance liquid chromatography using protein precipitation with trichloroacetic acid and ultraviolet detection.
J Chromatogr B Biomed Sci Appl. 1999 Nov 12;734(2):203-10. doi: 10.1016/s0378-4347(99)00345-x.
4
Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat.
J Pharm Biomed Anal. 2005 Sep 1;39(1-2):299-304. doi: 10.1016/j.jpba.2005.02.041. Epub 2005 Apr 25.
5
Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography.采用多微透析与液相色谱联用技术同时测定大鼠血液、脑和胆汁中的沙利度胺。
Biomed Chromatogr. 2005 Sep;19(7):488-93. doi: 10.1002/bmc.466.
6
Thalidomide enantiomers: determination in biological samples by HPLC and vancomycin-CSP.沙利度胺对映体:采用高效液相色谱法和万古霉素手性固定相法测定生物样品中的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):48-56. doi: 10.1016/j.jchromb.2005.11.023.
7
Determination of thalidomide by high performance liquid chromatography: methodological strategy for clinical trials.高效液相色谱法测定沙利度胺:临床试验的方法策略
Clin Biochem. 1995 Aug;28(4):467-70. doi: 10.1016/0009-9120(95)00019-6.
8
A Wide Linearity Range Method for the Determination of Lenalidomide in Plasma by High-Performance Liquid Chromatography: Application to Pharmacokinetic Studies.一种用高效液相色谱法测定血浆中来那度胺的宽线性范围方法:在药代动力学研究中的应用
J Lab Autom. 2016 Dec;21(6):806-810. doi: 10.1177/2211068216636570. Epub 2016 Mar 8.
9
Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-performance liquid chromatography with ultraviolet detection.采用带紫外检测的高效液相色谱法测定用于Caco-2细胞单层的转运缓冲液中的沙利度胺。
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 25;785(1):165-73. doi: 10.1016/s1570-0232(02)00911-x.
10
Enantiomers of thalidomide: blood distribution and the influence of serum albumin on chiral inversion and hydrolysis.沙利度胺的对映体:血液分布以及血清白蛋白对手性转化和水解的影响。
Chirality. 1998;10(3):223-8. doi: 10.1002/(SICI)1520-636X(1998)10:3<223::AID-CHIR4>3.0.CO;2-A.

引用本文的文献

1
Determination of thalidomide concentration in human plasma by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法测定人血浆中沙利度胺的浓度。
Exp Ther Med. 2013 Feb;5(2):626-630. doi: 10.3892/etm.2012.847. Epub 2012 Nov 30.
2
Clinical pharmacokinetics of thalidomide.沙利度胺的临床药代动力学
Clin Pharmacokinet. 2004;43(5):311-27. doi: 10.2165/00003088-200443050-00004.
3
Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancer.沙利度胺用于转移性结直肠癌患者的II期试验及药代动力学研究。
Invest New Drugs. 2003 Aug;21(3):359-66. doi: 10.1023/a:1025485031112.
4
Protective effect of pentoxifylline plus thalidomide against septic shock in mice.己酮可可碱联合沙利度胺对小鼠脓毒症休克的保护作用
Int J Exp Pathol. 1999 Feb;80(1):11-6. doi: 10.1046/j.1365-2613.1999.00085.x.
5
A double-blind study of the sedative effects of the thalidomide enantiomers in humans.沙利度胺对映体对人体镇静作用的双盲研究。
J Pharmacokinet Biopharm. 1998 Aug;26(4):363-83. doi: 10.1023/a:1021008016719.
6
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.具有增强的肿瘤坏死因子α抑制活性的沙利度胺新型类似物的筛选。
Mol Med. 1996 Jul;2(4):506-15.
7
Thalidomide: rationale for renewed use in immunological disorders.沙利度胺:在免疫性疾病中重新应用的理论依据。
Drug Saf. 1995 Jun;12(6):364-9. doi: 10.2165/00002018-199512060-00002.